GovWire

Defras Secretary of State has permitted the use of 3 unauthorised bluetongue serotype 3 (BTV-3) vaccines within the United Kingdom, subject to licence.

Although these vaccines are not authorised, the Veterinary Medicines Directorate (VMD) has assessed them. They consider the vaccines to be of a consistent quality and safety, and efficacy has been demonstrated. Therefore, they meet the administration criteria under Schedule 4 of the Veterinary Medicine Regulations 2013 (VMR 2013).

Unlike the authorised vaccines for other BTV serotypes, the BTV-3 vaccines claim to reduce viraemia rather than prevent it. This means they may not prevent your animals from being infected or infectious, but (depending on the vaccine) their claims include reduction or prevention of clinical signs experienced or mortality.

For this reason, all movement controls and trade restrictions still apply to vaccinated animals. You should not test vaccinated animals as part of a pre-movement test in bluetongue zones until 7 days after their vaccination. This will prevent interference with BTV-3 monitoring.

The general licence only allows vaccination in England. Scotland, Wales and Northern Ireland have not licensed the use of vaccination for BTV-3 but will keep this position under review.

Discuss the merits of vaccination for your animals and business with your private veterinarian.

If you have previously applied for a specific licence to vaccinate your animals against BTV-3, you can either:

• use the specific licence while it is valid
• use the general licence instead

Veterinarians should read theadvisory notebefore prescribing any BTV-3 vaccine.

Reporting your use of BTV-3 vaccinations

You must report your use of the BTV-3 vaccine as a condition of this licence.

Complete the vaccine reporting form within 48 hours of the date of vaccination.

This will meet your legal requirement under condition 3 of the general licence.